Sign In
Buy ZVRA
Zevra Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 9.90. In total, the insiders bought 3.95M and sold 472.26K ZVRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
9.90 |
| ● Buy | 3.95M shares |
| ● Sell | 472.26K shares |
|
77% Buy Activity
Moderate Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 29, 2025 Buy |
Favorito Tamara A Director |
30 000 Value: $258.6K |
||
|
May 29, 2025 Buy |
Watton Corey Michael Director |
30 000 Value: $258.6K |
||
|
May 29, 2025 Buy |
Bode John B Director |
30 000 Value: $258.6K |
||
|
May 29, 2025 Buy |
Anderson Thomas Director |
30 000 Value: $258.6K |
||
|
Mar 28, 2025 Buy |
Watton Corey Michael Director |
300 Value: $2K |
||
|
Mar 28, 2025 Buy |
Watton Corey Michael Director |
300 Value: $2K |
||
|
Mar 19, 2025 Buy |
Bode John B Director |
10 000 Value: $79.6K |
||
|
Mar 19, 2025 Buy |
Bode John B Director |
10 000 Value: $79.6K |
||
|
Feb 14, 2025 Sell |
Mcfarlane Neil F. President And CEO |
30 544 Value: $246.0K |
||
|
Feb 13, 2025 Sell |
Sangiovanni Timothy J. SVP, Finance & Corp Controller |
3 000 Value: $23.6K |
||
|
Feb 13, 2025 Sell |
Schafer Joshua Cco & EVP, Bus. Development |
10 500 Value: $82.5K |
||
|
Feb 13, 2025 Sell |
Clifton R. Laduane CFO & Treasurer |
11 000 Value: $86.5K |
||
|
Feb 13, 2025 Sell |
Mcfarlane Neil F. President And CEO |
61 273 Value: $481.4K |
||
|
Feb 13, 2025 Sell |
Sangiovanni Timothy J. SVP, Finance & Corp Controller |
3 000 Value: $23.6K |
||
|
Feb 13, 2025 Sell |
Schafer Joshua Cco & EVP, Bus. Development |
10 500 Value: $82.5K |
||
|
Feb 13, 2025 Sell |
Clifton R. Laduane CFO & Treasurer |
11 000 Value: $86.5K |
||
|
Feb 13, 2025 Sell |
Mcfarlane Neil F. President And CEO |
61 273 Value: $481.4K |
||
|
Jan 30, 2025 Buy |
Quartel Adrian W Chief Medical Officer |
68 000 Value: $545.4K |
||
|
Jan 30, 2025 Buy |
Quartel Adrian W Chief Medical Officer |
34 000 Value: $272.7K |
||
|
Jan 30, 2025 Buy |
Quartel Adrian W Chief Medical Officer |
68 000 Value: $545.4K |
||
|
Jan 30, 2025 Buy |
Quartel Adrian W Chief Medical Officer |
34 000 Value: $272.7K |
||
|
Dec 06, 2024 Buy |
Quartel Adrian W Chief Medical Officer |
0 Value: $0 |
||
|
Dec 06, 2024 Buy |
Quartel Adrian W Chief Medical Officer |
300 000 Value: $1.93M |
||
|
Dec 06, 2024 Buy |
Quartel Adrian W Chief Medical Officer |
0 Value: $0 |
||
|
Dec 06, 2024 Buy |
Quartel Adrian W Chief Medical Officer |
300 000 Value: $1.93M |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
